Cargando…
Targeting Aberrant Sialylation to Treat Cancer
Cell surface carbohydrates (known as glycans) are often aberrantly expressed or found at atypical levels in cancer. Glycans can impact all steps in tumour progression, from malignant transformation to metastasis, and have roles in all the cancer hallmarks. An increased understanding of glycans in th...
Autores principales: | Munkley, Jennifer, Scott, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963943/ https://www.ncbi.nlm.nih.gov/pubmed/31614918 http://dx.doi.org/10.3390/medicines6040102 |
Ejemplares similares
-
Aberrant Sialylation in Cancer: Therapeutic Opportunities
por: Munkley, Jennifer
Publicado: (2022) -
The Role of Sialyl-Tn in Cancer
por: Munkley, Jennifer
Publicado: (2016) -
Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
por: Pietrobono, Silvia, et al.
Publicado: (2021) -
Glycans as Biomarkers in Prostate Cancer
por: Scott, Emma, et al.
Publicado: (2019) -
Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis
por: Sturiale, Luisa, et al.
Publicado: (2021)